These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 9066187

  • 1. Prognosis of coronary arterial lesions in Kawasaki disease treated without intravenous immunoglobulin.
    Tzen KT, Wu MH, Wang JK, Lue HC, Lee CY, Chien SC.
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1997; 38(1):32-7. PubMed ID: 9066187
    [Abstract] [Full Text] [Related]

  • 2. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
    Qin LJ, Wang HW, Hu XF, Liu QJ, Shi H, Wei YX, Chen QJ, Cheng PX.
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):891-5. PubMed ID: 17254453
    [Abstract] [Full Text] [Related]

  • 3. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease.
    Mori M, Imagawa T, Yasui K, Kanaya A, Yokota S.
    J Pediatr; 2000 Aug; 137(2):177-80. PubMed ID: 10931408
    [Abstract] [Full Text] [Related]

  • 4. Outcome of coronary artery aneurysms after Kawasaki disease.
    Akagi T, Rose V, Benson LN, Newman A, Freedom RM.
    J Pediatr; 1992 Nov; 121(5 Pt 1):689-94. PubMed ID: 1432415
    [Abstract] [Full Text] [Related]

  • 5. [Study on coronary artery lesions in patients with Kawasaki disease: recent 9 years' experience].
    Wu JR, Hwang KP, Tu JG, Dai ZK, Huang TY.
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1993 Jan; 9(1):27-38. PubMed ID: 7682261
    [Abstract] [Full Text] [Related]

  • 6. Progressive Coronary Dilatation Predicts Worse Outcome in Kawasaki Disease.
    Chih WL, Wu PY, Sun LC, Lin MT, Wang JK, Wu MH.
    J Pediatr; 2016 Apr; 171():78-82.e1. PubMed ID: 26852179
    [Abstract] [Full Text] [Related]

  • 7. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
    Tse SM, Silverman ED, McCrindle BW, Yeung RS.
    J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
    [Abstract] [Full Text] [Related]

  • 8. [Kawasaki disease: new and important problems in cardiology].
    Kato H, Ichinose E.
    J Cardiogr; 1983 Sep; 13(3):731-47. PubMed ID: 6678300
    [Abstract] [Full Text] [Related]

  • 9. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
    Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM.
    Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
    [Abstract] [Full Text] [Related]

  • 10. Acute and late coronary outcomes in 1073 patients with Kawasaki disease with and without intravenous γ-immunoglobulin therapy.
    Lin MT, Sun LC, Wu ET, Wang JK, Lue HC, Wu MH.
    Arch Dis Child; 2015 Jun; 100(6):542-7. PubMed ID: 25564534
    [Abstract] [Full Text] [Related]

  • 11. Reevaluation of the efficacy of intravenous gammaglobulin in the prevention and treatment of coronary artery lesion in Kawasaki disease.
    Qin L, Saumu MT, Wang H, Shi H, Hu X, Cheng P.
    J Huazhong Univ Sci Technolog Med Sci; 2005 Jun; 25(3):348-50, 370. PubMed ID: 16201293
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Cardiac involvement in Kawasaki disease].
    Urcelay G, Hernández I, Farrú O, Arcil G, Godoy F.
    Rev Chil Pediatr; 1989 Jun; 60(6):315-9. PubMed ID: 2520836
    [Abstract] [Full Text] [Related]

  • 14. Long-term efficacy of plasma exchange treatment for refractory Kawasaki disease.
    Hokosaki T, Mori M, Nishizawa T, Nakamura T, Imagawa T, Iwamoto M, Yokota S.
    Pediatr Int; 2012 Feb; 54(1):99-103. PubMed ID: 22004042
    [Abstract] [Full Text] [Related]

  • 15. Clinical features of atypical Kawasaki disease.
    Hsieh YC, Wu MH, Wang JK, Lee PI, Lee CY, Huang LM.
    J Microbiol Immunol Infect; 2002 Mar; 35(1):57-60. PubMed ID: 11950122
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Risk factors for coronary artery lesions in children with Kawasaki disease].
    Li Y, Wang XM, Liu YL, Shi K, Yang YF, Guo YH.
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Dec; 14(12):938-41. PubMed ID: 23234782
    [Abstract] [Full Text] [Related]

  • 18. Assessment of intravenous immunoglobulin non-responders in Kawasaki disease.
    Hwang JY, Lee KY, Rhim JW, Youn YS, Oh JH, Han JW, Lee JS, Burgner D.
    Arch Dis Child; 2011 Nov; 96(11):1088-90. PubMed ID: 20551193
    [Abstract] [Full Text] [Related]

  • 19. Persistent monocytosis after intravenous immunoglobulin therapy correlated with the development of coronary artery lesions in patients with Kawasaki disease.
    Kuo HC, Wang CL, Liang CD, Yu HR, Chen HH, Wang L, Yang KD.
    J Microbiol Immunol Infect; 2007 Oct; 40(5):395-400. PubMed ID: 17932598
    [Abstract] [Full Text] [Related]

  • 20. [Kawasaki disease: clinical characteristics and cardiovascular involvement in a cohort of 121 patients].
    Calabri GB, Falcini F, Favilli S, Pollini I, Capuzzo L, Simonini G, De Simone L.
    Pediatr Med Chir; 2002 Oct; 24(5):352-7; discussion 397-9. PubMed ID: 12494535
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.